Practical Neurology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Practical Neurology 2005;5:63; doi:10.1111/j.1474-7766.2005.00283.x
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Carphology

Carphology by Rajendra

EXTRACT

The popularity of monoamine oxidase type B inhibitors (MAOIBs) in early Parkinson’s disease decreased after their use was found to be associated with increased mortality. But a recent meta-analysis of 17 randomised trials including 3525 patients showed no significant difference in mortality between patients taking MAOBIs and control patients. An accompanying editorial says these drugs clearly provide symptomatic benefit and probably entail no risk of increased mortality if they are used as monotherapy and in younger and otherwise healthy patients. As for their use in polytherapy and older people, the debate over mortality continues.

British Medical Journal, 2004, 329, 581–582.[Free Full Text]

MMR (mumps, measles and rubella) vaccination induces fever and predictably results in an increase in the rate of febrile seizures. A large and robust population based cohort study of over half a million children reported in JAMA confirms this. This increased rate of seizures was restricted to two weeks ...

[PDF of this article]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.